Drug Shortage Report for MYLAN-GLICLAZIDE MR
Report ID | 65715 |
Drug Identification Number | 02438658 |
Brand name | MYLAN-GLICLAZIDE MR |
Common or Proper name | MYLAN-GLICLAZIDE MR |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 30MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2018-12-10 |
Actual start date | 2018-12-10 |
Estimated end date | 2019-01-18 |
Actual end date | 2019-01-21 |
Shortage status | Resolved |
Updated date | 2019-01-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-10-29 | English | Compare |